Genome Editing Market Development And Business Intelligence

Summary

• Major factors influencing the growth of the market.
• Leading players & Top Segments.
• Geographic Overview.

Market growth influenced due to following factors-

• Rising government funding and growth in the number of genomics projects.
• High prevalence of infectious diseases and cancer.
• Growing application areas of genomics.

Global market size-

According to research report the global Genome Editing Market is projected to reach $6.28 billion by 2022, at a CAGR of 14.5% during the forecast period. 

Leading Players-

Some of the major players in the genome editing market are Thermo Fisher Scientific (US), Merck (Germany), Horizon Discovery Group (UK), GenScript (US), Sangamo BioSciences (US), Integrated DNA Technologies (US), Lonza Group (Switzerland), New England Biolabs (US), OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Editas Medicine (US), and CRISPR Therapeutics (Switzerland). 

Top Market Segments-

Based on technology, the genome engineering market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies (PiggyBac, Flp-In, Adenine Base Editor (ADE), and Jump-In). The CRISPR segment is expected to register the highest growth during the forecast period.

The global genome editing market, by application, is segmented into cell line engineering, genetic engineering, and other applications (diagnostics and therapeutics). The cell line engineering segment is estimated to register the highest growth rate during the forecast period.

 

For Details, Download PDF Brochure Here

Geographic Overview -

In 2017, North America is projected to have the highest growth rate during the forecast period. Factors such as the development of gene therapy in the US, increasing use of genetically modified crops, rising prevalence of infectious diseases and cancer, and rising availability of research grants and funding are propelling market growth in North America.